Publications
Books, Monographs and Reports
Make in India: An Assessment of the Impact of the Programme on Six Manufacturing Sectors
FDI in R&D and Development of National Innovation Capabilities: A Case Study of India
Journal Articles, Book Chapters, Working Papers and Policy Briefs
2026
India-Korea Economic Partnership: The Elusive Second Wave of Korean FDI, in Byungyul Park and Reji K. Joseph (Eds.), Korea-India Industrial Collaboration: Driving Shared Growth and Future Prosperity, KIET, Sejong, Korea and ISID, New Delhi, pp. 29–45.
2025
India-Korea Economic Cooperation: Trends, Issues and Way Forward to Deepen the Partnership, in Byungyul Park and Reji K. Joseph (Eds.), Reimagining India-Korea Economic Partnership: Pathways to Deeper Integration, ISID, New Delhi and KIET, Sejong, Korea, pp. 5–32 (Co-author, first author).
Deepening India-Korea Economic Engagement with a Focus on the Indian Manufacturing Sector, ISID Working Paper No. 294.
India’s Trade in Pharmaceutical Products: Recent Trends, in Sumangala Damodaran, Smita Gupta, Sona Mitra and Dipa Sinha (Eds.), Development, Transformations and the Human Condition: Essays in Honour of Jayati Ghosh, Routledge, London and New York.
2024
Making Global Pharma Supply Chain Resilient: Will the PLI Scheme of India Make It a Reliable Alternative to China for the Supply of APIs?, Indian Economic Journal, Online first, https://doi.org/10.1177/00194662241265475 (Co-author, corresponding author).
2023
Domestic Production of APIs in India, in Pradeep Mehta and Ujjwal Kumar (Eds.), Competition and Regulation in India 2023: Regulatory Deficit in Access to Equitable Healthcare, CUTS International, New Delhi, pp. 136–145.
2022
India’s Trade in Pharmaceutical Products: A Method for the Classification of Pharmaceutical Products and Recent Trends, ISID Working Paper No. 248 (Co-author, first author).
2021
Innovation, Patents and Competition in Modern Agriculture: A Case Study of Bayer and Monsanto Merger, The Antitrust Bulletin, Vol. 66, No. 2, pp. 214–224.
Doha Declaration on Public Health and India, in Seokwoo Lee (Ed.), Encyclopedia of Public International Law in Asia (3 Vols), Brill, The Netherlands, pp. 310–312.
Reducing Import Dependence on APIs in the Indian Pharmaceutical Sector: An Analysis of Early Experience of the PLI Phase-I Scheme, ISID Working Paper No. 239.
Outward FDI from India: Review of Policy and Emerging Trends, ISID Working Paper No. 214.
Making the TRIPS Agreement Work Effectively for the Public Health Challenges, ISID Policy Brief No. 21-03.
2020
Patents and Access to Medicines in Foreign Economic Policy, Indian Journal of Politics and International Relations, Special Issue, Vol. 12–13, 2019–2020, pp. 374–384.
COVID-19: An Opportunity for Pharma Exports, in AIC-EEPC (Eds.), COVID-19: Challenges for the Indian Economy – Trade and Foreign Policy Effects, ASEAN-India Centre (AIC) and Engineering Export Promotion Council of India (EEPC), New Delhi, pp. 140–143.
Outward FDI as a Strategy for Technology Catch-Up: A Case Study of Two Indian Automotive Firms, ISID Working Paper No. 229.
2019
India’s Information Technology Industry: A Tale of Two Halves, in Kung-Chung Liu and Uday Racherla (Eds.), Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors, Springer, Singapore (Co-author, second author).
The Challenges, Opportunities and Performance of the Indian Pharmaceutical Industry Post-TRIPS, in Kung-Chung Liu and Uday Racherla (Eds.), Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors, Springer, Singapore (Co-author, second author).
Standard Essential Patents and FRAND Licensing: A View from India, in Kung-Chung Liu and Reto M. Hilty (Eds.), SEPs, SSOs and FRAND: Asian and Global Perspectives on Fostering Innovation in Interconnectivity, Routledge, London and New York (Co-author, second author).
Investment Facilitation Agreement in WTO: Where Is It Headed?, in Lisa Sachs, Lise Johnson and Jesse Coleman (Eds.), Yearbook on International Investment Law & Policy 2017, Oxford University Press, Oxford, pp. 65–73.
FDI in R&D in India: An Analysis of Recent Trends, ISID Working Paper No. 209.
2018
Investment Facilitation: New Dynamism at the WTO on Investment, Columbia FDI Perspectives, No. 235, 24 September.
TRIPS and Public Health: Challenges for India and India’s Response, in Srinivas Burra and Rajesh Babu (Eds.), Locating India in Contemporary International Legal Order, Springer, New Delhi, pp. 235–254.
Book Review:Economic Growth and Its Distribution in India, edited by Pulapre Balakrishnan, The Book Review, October 2018.
2017
Multilateral Regime on Foreign Investment under WTO: A Hard Nut to Crack?, Journal of Political Economy and Fiscal Federalism, Vol. 3, pp. 21–31 (Co-author, first author).
National Innovation System: Experiences of India and China, in Girish Kumar (Ed.), Globalisation and India’s Innovation System: A Creative Destruction, Mahatma Gandhi University, Kerala.
Investment Facilitation in WTO: For Development?, ISID Policy Brief No. 3.
Investment Facilitation Agreement in WTO: What It Contains and Why India Should Be Cautious?, ISID Discussion Note.
2016
Foreign Direct Investment, Intellectual Property Rights and Technology Transfer, in Mousumi Das, Sabyasachi Kar and Nandan Nawn (Eds.), Economic Challenges for the Contemporary World: Essays in Honour of Prabhat Patnaik, Sage Publications, New Delhi, pp. 131–142 (Co-author, second author).
Trends in Foreign Investment in Healthcare Sector of India, ISID Working Paper No. 187.
National IPR Policy and Innovation, ISID Policy Brief No. 1.
2015
Developments in India’s Domestic Pharmaceutical Sector and Implications for Universal Healthcare in India, in Council for Social Development, India Social Development Report 2014: Challenges of Public Health, Oxford University Press, New Delhi (Co-author, second author).
2014
Political Economy of India’s Engagement with WTO: An Analysis in the Context of Amendment of India’s Patents Act, International Journal of South Asian Studies, Vol. 7, No. 1, pp. 35–49.
2012
The R&D Scenario in the Indian Pharmaceutical Industry, RIS Discussion Paper No. 176.
India’s Bilateral Agreements: Time to Review, Economic and Political Weekly, Vol. XLVII, No. 52, pp. 113–122 (Co-author, second author).
Approval of GM Crops: Socio-Economic Considerations in Developing Countries, Economic and Political Weekly, Vol. XLVII, No. 23, pp. 53–61 (Co-author, third author).
Policy Reforms in the Indian Pharmaceuticals Sector since 1994: Impact on Exports and Imports, Economic and Political Weekly, Vol. XLVII, No. 18, pp. 62–72.
2010
International Regime on Access and Benefit Sharing: Where Are We Now?, Asian Biotechnology and Development Review, Vol. 12, No. 3, pp. 77–94.
Anti-Counterfeiting Initiatives and Trade in Generic Medicines, Poverty in Focus (What Can IBSA Offer to the Global Community?), No. 21, UNDP – International Policy Centre for Inclusive Growth, pp. 20–22 (Co-author, second author).
India’s Engagement with the World Trade Organization: The Role of Non-State Agents, in Amitabh Mattoo and Happymon Jacob (Eds.), Shaping India’s Foreign Policy: People, Politics and Places, Har Anand Publishers, New Delhi, pp. 275–296.
2009
Estimating India’s Trade in Drugs and Pharmaceuticals, Economic and Political Weekly, Vol. XLIV, No. 2, pp. 18–23.
2007
Is GM Technology Desirable? The Law and Economics of Bt Cotton, in K. D. Raju (Ed.), Genetically Modified Organisms: Emerging Law and Policy in India, TERI Press, New Delhi.
2005
The TRIPS Agreement and the Developing Countries: An Analysis of Product Patent on Development, Availability and Prices of Drugs with Special Reference to India, in Debnarayan Sarkar (Ed.), Emerging Issues on Development, Gopa Guha, Kolkata, pp. 153–173.